STOCK TITAN
  1. Home
  2. Financials
  3. GRFS

Grifols S A Financials

GRFS
FY2025 annual
Revenue $206.0M YoY not available
Net Income $6.0M YoY not available
EPS (Diluted) Not reported for FY2025
Free Cash Flow Not reported for FY2025
Source SEC Filings (10-K/10-Q) Data as of Apr 17, 2026 Currency USD FYE April

Grifols S A (GRFS) reported $206.0M in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GRFS FY2025

Thin-margin, high-turnover operations are still producing profit, but they sit on a balance sheet with little cushion.

With $206M of revenue supported by only $81M of assets, the company is turning assets quickly; that helps explain how a modest 2.9% net margin still translates into a 7.4% return on assets. The result is a business with workable operating efficiency but negative equity of -$28M, so profits exist without much balance-sheet backing.

A current ratio of 0.6x means near-term obligations of $47M exceed current assets of $27M, so day-to-day liquidity depends more on steady turnover and access to funding than on cash or working-capital slack. In practice, profitable operations are carrying some of the burden that the balance sheet is not.

Only $8M of long-term debt against total liabilities of $103M suggests the strain is not mainly a term-debt problem. The deeper issue is liabilities outrunning assets by about $22M, which leaves shareholders without a meaningful accounting buffer despite positive net income of $6M.

Generated by Rhea from SEC filings [ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Grifols S A does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$206.0M

Grifols S A generated $206.0M in revenue in fiscal year 2025.

Net Income
$6.0M

Grifols S A reported $6.0M in net income in fiscal year 2025.

EBITDA

Not reported for fiscal year 2025.

EPS (Diluted)

Not reported for fiscal year 2025.

Cash & Balance Sheet

Cash & Debt
Debt $8.0M

Grifols S A carried $8.0M in long-term debt as of fiscal year 2025; cash and equivalents are not reported for that period.

Shares Outstanding
426M

Grifols S A had 426M shares outstanding in fiscal year 2025.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Net Margin
2.9%

Grifols S A's net profit margin was 2.9% in fiscal year 2025, showing the share of revenue converted to profit.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

None of these metrics is reported for fiscal year 2025.

GRFS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

GRFS annual income statement
MetricFY25
Revenue$206.0M
Net Income$6.0M

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, Interest Expense, Income Tax, EPS (Diluted).

GRFS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

GRFS annual balance sheet
MetricFY25
Total Assets$81.0M
Current Assets$27.0M
Total Liabilities$103.0M
Current Liabilities$47.0M
Long-Term Debt$8.0M
Total Equity-$28.0M

Not reported in any period shown, so not listed: Cash & Equivalents, Inventory, Accounts Receivable, Goodwill, Retained Earnings.

GRFS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

GRFS annual financial ratios
MetricFY25
Net Margin2.9%
Return on Assets7.4%
Current Ratio0.57

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Return on Equity, Debt-to-Equity, FCF Margin.

Note: Shareholder equity is negative (-$28.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.57), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

ORGANON & CO OGN
$3.6B
Elanco Animal Health ELAN
$12.0B
Biogen Inc BIIB
$32.0B
Pfizer PFE
$160.0B
Sanofi FR SNY
$109.9B

Frequently Asked Questions

What is Grifols S A's annual revenue?

Grifols S A (GRFS) reported $206.0M in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is Grifols S A profitable?

Yes, Grifols S A (GRFS) reported a net income of $6.0M in fiscal year 2025, with a net profit margin of 2.9%.

What is Grifols S A's net profit margin?

Grifols S A (GRFS) had a net profit margin of 2.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Grifols S A (GRFS) had $81.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Grifols S A (GRFS) had 426M shares outstanding as of fiscal year 2025.

Grifols S A (GRFS) had a current ratio of 0.57 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Grifols S A (GRFS) had a return on assets of 7.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Grifols S A (GRFS) has negative shareholder equity of -$28.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Back to top